Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).

Farmer P, Léandre F, Mukherjee J, Gupta R, Tarter L, Kim JY.

Bull World Health Organ. 2001;79(12):1145-51.

PMID:
11799447
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.

Behforouz HL, Farmer PE, Mukherjee JS.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S429-36.

PMID:
15156434
[PubMed - indexed for MEDLINE]
Free Article
3.

Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.

Koenig SP, Léandre F, Farmer PE.

AIDS. 2004 Jun;18 Suppl 3:S21-5.

PMID:
15322480
[PubMed - indexed for MEDLINE]
4.

Tuberculosis, poverty, and "compliance": lessons from rural Haiti.

Farmer P, Robin S, Ramilus SL, Kim JY.

Semin Respir Infect. 1991 Dec;6(4):254-60.

PMID:
1810004
[PubMed - indexed for MEDLINE]
5.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
[PubMed - indexed for MEDLINE]
6.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
7.

Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.

Harries AD, Hargreaves NJ, Chimzizi R, Salaniponi FM.

Bull World Health Organ. 2002;80(6):464-9.

PMID:
12132003
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: implementation of a program of highly active antiretroviral therapy in a resource-poor setting.

Kline MW, Matusa RF, Copaciu L, Calles NR, Kline NE, Schwarzwald HL.

Pediatr Infect Dis J. 2004 Aug;23(8):695-700.

PMID:
15295217
[PubMed - indexed for MEDLINE]
9.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
10.

Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients.

García de Olalla P, Martínez-González MA, Caylà JA, Jansà JM, Iglesias B, Guerrero R, Marco A, Gatell JM, Ocaña I; Barcelona AIDS-TB Study Group.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1051-7.

PMID:
12546112
[PubMed - indexed for MEDLINE]
11.

Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

Krentz HB, Kliewer G, Gill MJ.

HIV Med. 2005 Mar;6(2):99-106.

PMID:
15807715
[PubMed - indexed for MEDLINE]
12.

AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?

Borrell C, Rodríguez-Sanz M, Pasarín MI, Brugal MT, García-de-Olalla P, Marí-Dell'Olmo M, Caylà J.

Eur J Public Health. 2006 Dec;16(6):601-8. Epub 2006 May 12.

PMID:
16698886
[PubMed - indexed for MEDLINE]
Free Article
13.

Doubts about DOT: antiretroviral therapy for resource-poor countries.

Liechty CA, Bangsberg DR.

AIDS. 2003 Jun 13;17(9):1383-7.

PMID:
12799560
[PubMed - indexed for MEDLINE]
14.

The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.

Perumal R, Padayatchi N, Stiefvater E.

BMC Public Health. 2009 Jul 16;9:243. doi: 10.1186/1471-2458-9-243.

PMID:
19607697
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Community-based DOT-HAART accompaniment in an urban resource-poor setting.

Muñoz M, Finnegan K, Zeladita J, Caldas A, Sanchez E, Callacna M, Rojas C, Arevalo J, Sebastian JL, Bonilla C, Bayona J, Shin S.

AIDS Behav. 2010 Jun;14(3):721-30. doi: 10.1007/s10461-009-9559-5. Epub 2009 Apr 16.

PMID:
19370409
[PubMed - indexed for MEDLINE]
16.

Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti.

Walton DA, Farmer PE, Lambert W, Léandre F, Koenig SP, Mukherjee JS.

J Public Health Policy. 2004;25(2):137-58.

PMID:
15255381
[PubMed - indexed for MEDLINE]
17.

Plasma HIV-1 RNA to guide patient selection for antiretroviral therapy in resource-poor settings: efficiency related to active case finding.

Bogaards JA, Weverling GJ, Zwinderman AH, Bossuyt PM, Goudsmit J.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):232-7.

PMID:
16394857
[PubMed - indexed for MEDLINE]
18.

Antiretroviral treatment in resource-poor settings: the Brazilian experience.

Teixeira PR, Vitória MA, Barcarolo J.

AIDS. 2004 Jun;18 Suppl 3:S5-7.

PMID:
15322477
[PubMed - indexed for MEDLINE]
19.

Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting.

Torti C, Casari S, Palvarini L, Quiros-Roldan E, Moretti F, Leone L, Patroni A, Castelli F, Ripamonti D, Tramarin A, Carosi G.

Health Policy. 2003 Sep;65(3):261-7.

PMID:
12941493
[PubMed - indexed for MEDLINE]
20.

Human resources requirements for highly active antiretroviral therapy scale-up in Malawi.

Muula AS, Chipeta J, Siziya S, Rudatsikira E, Mataya RH, Kataika E.

BMC Health Serv Res. 2007 Dec 19;7:208.

PMID:
18093318
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk